Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Tympanic Membrane Perforation: early-phase trial registry

1 of 4 indexed Tympanic Membrane Perforation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Tympanic Membrane Perforation: 4 US clinical trials tracked, 1 recruiting.

Tympanic Membrane Perforation is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tympanogen, running 1 of these trials.

Enrollment posture brief

Registry condition tympanic-membrane-perforation

OPEN 1 | RECR 25% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Tympanic Membrane Perfor (th…25%
Open-enrollment share among volume-matched conditions near Tympanic Membrane Perforation

Tympanic Membrane Perforation lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tympanic Membrane Perforation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tympanic Membrane Perforation is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Tympanic Membrane Perforation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

FGF-2 Drug
1 trials
Perf-Fix Otologic Gel Patch Device
1 trials
Tympanoseal Device
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Tympanic Membrane Perforation trials. A trial with sites in several states counts in each.

Tennessee 2 trials
Massachusetts 2 trials
Virginia 1 trials
Texas 1 trials
Oregon 1 trials
North Carolina 1 trials
Michigan 1 trials
Louisiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tympanic Membrane Perforation page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Tympanic Membrane Perforation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Tympanogen sponsors the most Tympanic Membrane Perforation trials on record, review their full trial history before evaluating a specific study. See Tympanogen's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tympanic Membrane Perforation condition card totals 4 registered trials; most-linked intervention FGF-2; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.